Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group.
1994; Lippincott Williams & Wilkins; Volume: 90; Issue: 6 Linguagem: Inglês
10.1161/01.cir.90.6.3125
ISSN1524-4539
AutoresThomas A. Pearson, E Rapaport, Michael H. Criqui, Curt D. Furberg, Valentı́n Fuster, L Hiratzka, William Little, Ira S. Ockene, George W. Williams,
Tópico(s)Cardiac, Anesthesia and Surgical Outcomes
ResumoHomeCirculationVol. 90, No. 6Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBOptimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group. T Pearson, E Rapaport, M Criqui, C Furberg, V Fuster, L Hiratzka, W Little, I Ockene and G Williams T PearsonT Pearson Office of Scientific Affairs, Dallas, TX 75231-4596. , E RapaportE Rapaport Office of Scientific Affairs, Dallas, TX 75231-4596. , M CriquiM Criqui Office of Scientific Affairs, Dallas, TX 75231-4596. , C FurbergC Furberg Office of Scientific Affairs, Dallas, TX 75231-4596. , V FusterV Fuster Office of Scientific Affairs, Dallas, TX 75231-4596. , L HiratzkaL Hiratzka Office of Scientific Affairs, Dallas, TX 75231-4596. , W LittleW Little Office of Scientific Affairs, Dallas, TX 75231-4596. , I OckeneI Ockene Office of Scientific Affairs, Dallas, TX 75231-4596. and G WilliamsG Williams Office of Scientific Affairs, Dallas, TX 75231-4596. Originally published1 Dec 1994https://doi.org/10.1161/01.CIR.90.6.3125Circulation. 1994;90:3125–3133 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Alldred D, Booth C and Chrystyn H (2011) Development of a pharmacist-led cholesterol screening and lipid-lowering medication review service in coronary artery bypass graft patients, International Journal of Pharmacy Practice, 10.1111/j.2042-7174.2001.tb01059.x, 9:4, (275-281), Online publication date: 22-Feb-2011. Shahzadi N, Butt M, Sharif M and Nasir M (2007) Effect of guar gum on the serum lipid profile of Sprague Dawley rats, LWT - Food Science and Technology, 10.1016/j.lwt.2006.08.007, 40:7, (1198-1205), Online publication date: 1-Sep-2007. Butt M, Shahzadi N, Sharif M and Nasir M (2007) Guar Gum: A Miracle Therapy for Hypercholesterolemia, Hyperglycemia and Obesity, Critical Reviews in Food Science and Nutrition, 10.1080/10408390600846267, 47:4, (389-396), Online publication date: 26-Apr-2007. Lajos T, Robicsek F, Thubrikar M and Urschel H (2007) Improving Patency of Coronary Conduits "Valveless" Veins and/or Arterial Grafts, Journal of Cardiac Surgery, 10.1111/j.1540-8191.2007.00380.x, 22:2, (170-177), Online publication date: 1-Mar-2007. Kulik A, Le May M, Wells G, Mesana T and Ruel M (2005) The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423], Current Controlled Trials in Cardiovascular Medicine, 10.1186/1468-6708-6-15, 6:1, Online publication date: 1-Dec-2005. Adams K (2004) Cardiac Rehabilitation and Exercise Handbook of Clinical Nutrition and Aging, 10.1007/978-1-59259-391-0_17, (419-436), . Sprecher D, Watkins T, Behar S, Brown W, Rubins H and Schaefer E (2003) Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease, The American Journal of Cardiology, 10.1016/S0002-9149(02)03309-X, 91:5, (575-580), Online publication date: 1-Mar-2003. Liao L and Kong D (2003) Angiographic changes in vein grafts: Stable surrogate or seductive siren?, American Heart Journal, 10.1067/mhj.2003.114, 145:2, (187-189), Online publication date: 1-Feb-2003. Sethi P, Nance J, Johnson D, Wilke J, Wilson K, Hall R, Romero-Vagedes F, Wilson C, Jones W, Dye D, Dzurick J, Ohm J, Ericson P, Wendel C, Mohler J, Dahiya R, Dick E, Thai H, Goldman S, Rhenman B and Morrison D (2003) A Comprehensive Cardiac Rehabilitation Program in Post-CABG Patients, Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 10.1097/00132577-200303000-00004, 2:1, (20-33), Online publication date: 1-Mar-2003. Goff D, Gu L, Cantley L, Sheedy D and Cohen S (2003) Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial, American Heart Journal, 10.1016/S0002-8703(03)00522-2, 146:6, (1045-1051), Online publication date: 1-Dec-2003. Sethi P, Nance J, Johnson D, Wilke J, Wilson K, Hall R, Romero-Vagedes F, Wilson C, Jones W, Dye D, Dzurick J, Ohm J, Ericson P, Wendel C, Mohler J, Dahiya R, Dick E, Thai H, Goldman S, Rhenman B and Morrison D (2003) A Comprehensive Cardiac Rehabilitation Program in Post-CABG Patients, Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 10.1097/01.HPC.0000057391.93352.AA, 2:1, (20-33), Online publication date: 1-Mar-2003. Charlson M and Isom O (2003) Care after Coronary-Artery Bypass Surgery, New England Journal of Medicine, 10.1056/NEJMcp010691, 348:15, (1456-1463), Online publication date: 10-Apr-2003. Levin R, Koenig K, Corder M, Bhalla N, Rosenzweig B and Recht P (2002) Risk Stratification and Prevention in Chronic Coronary Artery Disease: Use of a Novel Prognostic and Computer-Based Clinical Decision Support System in a Large Primary Managed-Care Group Practice, Disease Management, 10.1089/10935070260474976, 5:4, (197-213), Online publication date: 1-Dec-2002. King K, Quinn J, Delehanty J, Rizzo S, Eldredge D, Caufield L and Ling F (2002) Perception of risk for coronary heart disease in women undergoing coronary angiography, Heart & Lung, 10.1067/mhl.2002.126522, 31:4, (246-252), Online publication date: 1-Jul-2002. Schaefer E (2002) Lipoproteins, nutrition, and heart disease, The American Journal of Clinical Nutrition, 10.1093/ajcn/75.2.191, 75:2, (191-212), Online publication date: 1-Feb-2002. Mangano D (2002) Aspirin and Mortality from Coronary Bypass Surgery, New England Journal of Medicine, 10.1056/NEJMoa020798, 347:17, (1309-1317), Online publication date: 24-Oct-2002. Iwama Y, Mokuno H, Watanabe Y, Shimada K, Yokoi H, Daida H, Hosoda Y and Yamaguchi H (2001) Relationship between Plasma Homocysteine Levels and Saphenous Vein Graft Disease after Coronary Artery Bypass Grafts., Japanese Heart Journal, 10.1536/jhj.42.553, 42:5, (553-562), . Marschner I, Colquhoun D, Simes R, Glasziou P, Harris P, Singh B, Friedlander D, White H, Thompson P and Tonkin A (2001) Long-term risk stratification for survivors of acute coronary syndromes, Journal of the American College of Cardiology, 10.1016/S0735-1097(01)01360-2, 38:1, (56-63), Online publication date: 1-Jul-2001. ARAK-LUKMANN A, P??RNA K and MAAROOS J (2001) An instrument for assessing health-related quality of life after surgical revascularization of myocardium in complex cardiac rehabilitation, International Journal of Rehabilitation Research, 10.1097/00004356-200109000-00010, 24:3, (235-239), Online publication date: 1-Sep-2001. King K and Mosca L (2007) Prevention of Heart Disease in Women: Recommendations for Management of Risk Factors, Progress in Cardiovascular Nursing, 10.1111/j.0889-7204.2000.080396.x, 15:2, (36-42), Online publication date: 1-Mar-2000. Liebson P and Amsterdam E (2000) Prevention of coronary heart disease, Disease-a-Month, 10.1016/S0011-5029(00)90016-6, 46:1, (1-123), Online publication date: 1-Jan-2000. Alaupovic P (2000) Management of dyslipidemia after coronary artery bypass grafting, Current Opinion in Lipidology, 10.1097/00041433-200008000-00005, 11:4, (369-375), Online publication date: 1-Aug-2000. Maglish B, Schwartz J and Matheny R (1999) Outcomes Improvement Following Minimally Invasive Direct Coronary Artery Bypass Surgery, Critical Care Nursing Clinics of North America, 10.1016/S0899-5885(18)30160-6, 11:2, (177-188), Online publication date: 1-Jun-1999. Zhang W, Bai H, Sawa Y, Yamakawa T, Kadoba K, Taniguchi K, Masuda J, Ogata J, Shirakura R and MD H (1999) Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts, Journal of Vascular Surgery, 10.1016/S0741-5214(99)70189-8, 30:1, (169-183), Online publication date: 1-Jul-1999. (1999) Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease, New England Journal of Medicine, 10.1056/NEJM199912093412415, 341:24, (1853-1855), Online publication date: 9-Dec-1999. Kimble L (2016) Cognitive Appraisal and Cardiac Risk Reduction Behavior Following Coronary Angioplasty, Western Journal of Nursing Research, 10.1177/019394599802000605, 20:6, (733-744), Online publication date: 1-Dec-1998. Simons-Morton D and Cutler J (1998) Cardiovascular Disease Prevention Research at the National Heart, Lung, and Blood Institute, American Journal of Preventive Medicine, 10.1016/S0749-3797(97)00057-3, 14:4, (317-330), Online publication date: 1-May-1998. Wood D, De Backer G, Faergeman O, Graham I, Mancia G and Pyörälä K (1998) Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2, Atherosclerosis, 10.1016/S0021-9150(98)90209-X, 140:2, (199-270), Online publication date: 1-Oct-1998. Smith S (1998) Risk Reduction Therapies for Patients with Coronary Artery Disease: A Call for Increased Implementation, The American Journal of Medicine, 10.1016/S0002-9343(98)00043-6, 104:2, (23S-26S), Online publication date: 1-Feb-1998. MOSCA L, McGILLEN C and RUBENFIRE M (1998) Gender Differences in Barriers to Lifestyle Change for Cardiovascular Disease Prevention, Journal of Women's Health, 10.1089/jwh.1998.7.711, 7:6, (711-715), Online publication date: 1-Aug-1998. Grundy S (2015) Cholesterol management in high-risk patients without heart disease, Postgraduate Medicine, 10.3810/pgm.1998.11.405, 104:5, (117-129), Online publication date: 1-Nov-1998. Peduzzi P, Kamina A and Detre K (1998) Twenty-Two-Year Follow-Up in the VA Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina, The American Journal of Cardiology, 10.1016/S0002-9149(98)00204-5, 81:12, (1393-1399), Online publication date: 1-Jun-1998. Eisenberg M, Califf R, Cohen E, Adelman A, Mark D and Topol E (1997) Use of Evidence-Based Medical Therapy in Patients Undergoing Percutaneous Coronary Revascularization in the United States, Europe, and Canada, The American Journal of Cardiology, 10.1016/S0002-9149(97)00005-2, 79:7, (867-872), Online publication date: 1-Apr-1997. Fuster V and Vorchheimer D (1997) Prevention of Atherosclerosis in Coronary-Artery Bypass Grafts, New England Journal of Medicine, 10.1056/NEJM199701163360309, 336:3, (212-213), Online publication date: 16-Jan-1997. Allen J and Xu X (1997) Coronary Revascularization in Women, Critical Care Nursing Clinics of North America, 10.1016/S0899-5885(18)30243-0, 9:4, (497-509), Online publication date: 1-Dec-1997. Wenger N (1996) Treatment of Hyperlipidemia in Women Drugs Affecting Lipid Metabolism, 10.1007/978-94-009-0311-1_49, (425-438), . Pearson T and Swan H (1996) LIPID LOWERING, Cardiology Clinics, 10.1016/S0733-8651(05)70265-4, 14:1, (117-130), Online publication date: 1-Feb-1996. Swan H, Gersh B, Graboys T and Ullyot D (1996) Task force 7. Evaluation and management of risk factors for the individual patient (case management), Journal of the American College of Cardiology, 10.1016/0735-1097(96)87735-7, 27:5, (1030-1039), Online publication date: 1-Apr-1996. Rapaport E and Gheorghiade M (1996) Pharmacologic therapies after myocardial infarction, The American Journal of Medicine, 10.1016/S0002-9343(96)00322-1, 101:4, (61S-70S), Online publication date: 1-Oct-1996. Pearson T, McBride P, Miller N and Smith S (1996) Task force 8. Organization of preventive cardiology service, Journal of the American College of Cardiology, 10.1016/0735-1097(96)87736-9, 27:5, (1039-1047), Online publication date: 1-Apr-1996. Chaux A, Ruan X, Fishbein M, Sandhu M and Matloff J (1995) Influence of vein valves in the development of arteriosclerosis in venoarterial grafts in the rabbit, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/S0022-5223(95)70061-7, 110:5, (1381-1390), Online publication date: 1-Nov-1995. Hiratzka L (1995) Secondary prevention of atherosclerosis: Emphasizing risk factor management to patients, The Annals of Thoracic Surgery, 10.1016/S0003-4975(95)00382-7, 60:1, (1), Online publication date: 1-Jul-1995. December 1, 1994Vol 90, Issue 6 Advertisement Article InformationMetrics Copyright © 1994 by American Heart Associationhttps://doi.org/10.1161/01.CIR.90.6.3125 Originally publishedDecember 1, 1994 PDF download Advertisement
Referência(s)